AAAAAA

   
Results: 1-25 | 26-38 |
Results: 26-38/38
LABELING SMALL QUANTITIES OF MONOCLONAL-ANTIBODIES AND THEIR F(AB')(2) FRAGMENTS WITH TC-99M
Authors: TESIC M SHELDON KM BALLINGER JR BOXEN I
Citation: M. Tesic et al., LABELING SMALL QUANTITIES OF MONOCLONAL-ANTIBODIES AND THEIR F(AB')(2) FRAGMENTS WITH TC-99M, Nuclear medicine and biology, 22(4), 1995, pp. 451-457
P-31 CHANGES AS A MEASURE OF THERAPY RESPONSE IN RESISTANT AND SENSITIVE OSTEOSARCOMAS IMPLANTED INTO NUDE-MICE
Authors: BALLINGER JR KANG H SWEENEY CA SCOTT JD CROKER BP SCOTT KN
Citation: Jr. Ballinger et al., P-31 CHANGES AS A MEASURE OF THERAPY RESPONSE IN RESISTANT AND SENSITIVE OSTEOSARCOMAS IMPLANTED INTO NUDE-MICE, Magnetic resonance imaging, 13(6), 1995, pp. 877-883
UNTITLED - REPLY
Authors: BALLINGER JR SCOTT KN
Citation: Jr. Ballinger et Kn. Scott, UNTITLED - REPLY, Magnetic resonance imaging, 13(3), 1995, pp. 496-496
P-31 CHANGES AS A MEASURE OF THERAPY RESPONSE IN HUMAN OSTEOSARCOMAS IMPLANTED INTO NUDE-MICE (VOL 12, PG 935, 1994)
Authors: KANG H BALLINGER JR SWEENEY C CROKER BP SCOTT KN
Citation: H. Kang et al., P-31 CHANGES AS A MEASURE OF THERAPY RESPONSE IN HUMAN OSTEOSARCOMAS IMPLANTED INTO NUDE-MICE (VOL 12, PG 935, 1994), Magnetic resonance imaging, 13(3), 1995, pp. 499-499
TC-99(M)-SESTAMIBI AS AN AGENT FOR IMAGING P-GLYCOPROTEIN-MEDIATED MULTIDRUG-RESISTANCE - IN-VITRO AND IN-VIVO STUDIES IN A RAT BREAST-TUMOR CELL-LINE AND ITS DOXORUBICIN-RESISTANT VARIANT
Authors: BALLINGER JR HUA HA BERRY BW FIRBY P BOXEN I
Citation: Jr. Ballinger et al., TC-99(M)-SESTAMIBI AS AN AGENT FOR IMAGING P-GLYCOPROTEIN-MEDIATED MULTIDRUG-RESISTANCE - IN-VITRO AND IN-VIVO STUDIES IN A RAT BREAST-TUMOR CELL-LINE AND ITS DOXORUBICIN-RESISTANT VARIANT, Nuclear medicine communications, 16(4), 1995, pp. 253-257
A NOVEL ANTI-SEMINOMA MONOCLONAL-ANTIBODY (M2A) LABELED WITH TC-99M -POTENTIAL APPLICATION FOR RADIOIMMUNOSCINTIGRAPHY
Authors: MARKS A BALLINGER JR REILLY RM LAW J BAUMAL R
Citation: A. Marks et al., A NOVEL ANTI-SEMINOMA MONOCLONAL-ANTIBODY (M2A) LABELED WITH TC-99M -POTENTIAL APPLICATION FOR RADIOIMMUNOSCINTIGRAPHY, British Journal of Urology, 75(2), 1995, pp. 225-229
P-31 CHANGES AS A MEASURE OF THERAPY RESPONSE IN HUMAN OSTEOSARCOMAS IMPLANTED INTO NUDE-MICE
Authors: KANG H BALLINGER JR SWEENEY C CROKER BP SCOTT KN
Citation: H. Kang et al., P-31 CHANGES AS A MEASURE OF THERAPY RESPONSE IN HUMAN OSTEOSARCOMAS IMPLANTED INTO NUDE-MICE, Magnetic resonance imaging, 12(6), 1994, pp. 935-943
A BASIS FOR SEMIQUANTITATIVE MEASUREMENT OF THE DOPAMINE D2 RECEPTOR DENSITY USING EQUILIBRIUM-ANALYSIS WITH BOLUS PLUS REINJECTION BY CONSTANT INFUSION OF I-125 IBZM
Authors: TOYAMA H MATSUMURA K NAKASHIMA H MAEDA H ICHISE M BALLINGER JR TAKEUCHI A KOGA S NAKAGAWA T
Citation: H. Toyama et al., A BASIS FOR SEMIQUANTITATIVE MEASUREMENT OF THE DOPAMINE D2 RECEPTOR DENSITY USING EQUILIBRIUM-ANALYSIS WITH BOLUS PLUS REINJECTION BY CONSTANT INFUSION OF I-125 IBZM, The Journal of nuclear medicine, 35(5), 1994, pp. 160000202-160000202
A POTENTIALLY ARTIFACT-FREE ORAL CONTRAST AGENT FOR GASTROINTESTINAL MRI
Authors: LIEBIG T STOUPIS C ROS PR BALLINGER JR BRIGGS RW
Citation: T. Liebig et al., A POTENTIALLY ARTIFACT-FREE ORAL CONTRAST AGENT FOR GASTROINTESTINAL MRI, Magnetic resonance in medicine, 30(5), 1993, pp. 646-649
MECHANISMS THAT CONTRIBUTE TO THE IN-VITRO RELAXATION AND SIGNAL INTENSITY OF WATER IN BARIUM-SULFATE SUSPENSIONS USED AS MRI CONTRAST AGENTS
Authors: BRIGGS RW LIEBIG T BALLINGER JR ROS PR
Citation: Rw. Briggs et al., MECHANISMS THAT CONTRIBUTE TO THE IN-VITRO RELAXATION AND SIGNAL INTENSITY OF WATER IN BARIUM-SULFATE SUSPENSIONS USED AS MRI CONTRAST AGENTS, Magnetic resonance imaging, 11(5), 1993, pp. 635-644
IODINE-123-IBZM DOPAMINE-D2 RECEPTOR AND TECHNETIUM-99M-HMPAO BRAIN PERFUSION SPECT IN THE EVALUATION OF PATIENTS WITH AND SUBJECTS AT RISKFOR HUNTINGTONS-DISEASE
Authors: ICHISE M TOYAMA H FORNAZZARI L BALLINGER JR KIRSH JC
Citation: M. Ichise et al., IODINE-123-IBZM DOPAMINE-D2 RECEPTOR AND TECHNETIUM-99M-HMPAO BRAIN PERFUSION SPECT IN THE EVALUATION OF PATIENTS WITH AND SUBJECTS AT RISKFOR HUNTINGTONS-DISEASE, The Journal of nuclear medicine, 34(8), 1993, pp. 1274-1281
ROLE OF P-GLYCOPROTEIN (PGP) IN ACCUMULATION OF TL-201 (TL) AND TC-99M SESTAMIBI (MIBI) IN TUMOR-CELLS
Authors: BALLINGER JR SHELDON K BOXEN I ERLICHMAN C LING V
Citation: Jr. Ballinger et al., ROLE OF P-GLYCOPROTEIN (PGP) IN ACCUMULATION OF TL-201 (TL) AND TC-99M SESTAMIBI (MIBI) IN TUMOR-CELLS, The Journal of nuclear medicine, 34(5), 1993, pp. 242-242
IMPROVED METHOD TO LABEL BETA-2 AGONISTS IN METERED-DOSE INHALERS WITH TC-99M
Authors: BALLINGER JR CALCUTT LE HODDER RV PROULX A GULENCHYN KY
Citation: Jr. Ballinger et al., IMPROVED METHOD TO LABEL BETA-2 AGONISTS IN METERED-DOSE INHALERS WITH TC-99M, Journal of aerosol science, 24(6), 1993, pp. 787-794
Risultati: 1-25 | 26-38 |